Sign in

Husam Alzayer

@husamjz.bsky.social
600 followers 440 following 1 posts

#Nephrologist on a learning mission! #KIreports graphic designer, #NSMC #NephEdC faculty, and #NephJC team member

PostsRepliesMedia
Reposted by Husam Alzayer
ISNkidneycare @theisn.org · 04/09/2026
📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Anti-CD20 Therapies and Antinephrin Autoantibodies in IgA Nephropathy With Minimal Change Disease www.kireports.org/article/S2468-024…
054
Reposted by Husam Alzayer
kireports.bsky.social @kireports.bsky.social · 16/04/2026
1/20 Hello everyone, welcome to www.kireportscommunity.org #Nephsky #Medsky Welcome to a #skytorial brought to you by @KIReports
kireportscommunity.org
Kidney Education | KI Reports Community
KI Reports Community is the blog page affiliated with KI Reports and the ISN, representing a less restricted space where a variety of content is presented, including expert commentaries, article summa...
142
Reposted by Husam Alzayer
Nephrology Journal Club @nephjc.bsky.social · 03/04/2026
🚨 #NephJC short 🩳from @kidneyboy.bsky.social The PUSH trial! 😉Can a wink, a nudge & a push encourage kidney stone formers to drink more fluid to prevent recurrence 🪨? (Hint: have 💦 behavioral trials worked in CHF or PCKD?) #NephSky #MedSky www.nephjc.com/news/2026/4/2/nephjc-short-the-push-trial
nephjc.com
NephJC Short: The Push Trial — NephJC
Water, water everywhere. Can a wink, a nudge and a push increase water intake to decrease kidney stone formation?
069
Reposted by Husam Alzayer
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 21/02/2026
Real-World Hospitalization Outcomes with On-Line Hemodiafiltration Versus High-Flux Hemodialysis ca. 2025 from @asnpublications.bsky.social #Nephpearls #NephSky #VisualAbstract by @husamjz.bsky.social 👉 pubmed.ncbi.nlm.nih.gov/41433104/
144
Reposted by Husam Alzayer
Nephrology Journal Club @nephjc.bsky.social · 12/01/2026
Check out the VA for VALIANT from @nephromommy-akshu.bsky.social #NephJC www.nephjc.com/news/2026/1/11/valiant-the-visual-abstract
nephjc.com
VALIANT: The Visual Abstract — NephJC
The VALIANT phase 3 RCT shows that proximal C3 inhibition with pegcetacoplan leads to a significantly greater reduction in proteinuria compared with placebo in patients with C3G and primary immune-com...
01310
Reposted by Husam Alzayer
kireports.bsky.social @kireports.bsky.social · 12/01/2026
Home-based #Exercise Improves #Muscle #Oxidative Capacity in #Kidney #Disease #VisualAbstract by Husam Alzayer www.kireports.org/article/S2468-024… Gwenaelle Begue Armin Ahmadi, PhD Bob Roshanravan
033
Reposted by Husam Alzayer
Nephrology Journal Club @nephjc.bsky.social · 12/12/2025
1/10 Welcome to #TenPostNephJC Last #NephJC we discussed the PISCES study 🐟 on the role of fish oil on cardiovascular events in hemodialysis patients. This study was presented at Kidney Week with simultaneous publication, and was as unexpected as a shark attack🦈.
188
Reposted by Husam Alzayer
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 01/12/2025
We are live The @theisn.org launches a new journal www.sciencedirect.com/journal/kidn...
sciencedirect.com
Kidney International Case Reports | Journal | ScienceDirect.com by Elsevier
Read the latest articles of Kidney International Case Reports at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
43212
Reposted by Husam Alzayer
Nephrology Journal Club @nephjc.bsky.social · 01/12/2025
Maybe the most shocking study from #KidneyWk. 🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊? www.nephjc.com/news/pisces-fishoil
nephjc.com
Fish Oil in Dialysis: A Big Catch or an Empty Net — NephJC
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
02016
Reposted by Husam Alzayer
kireports.bsky.social @kireports.bsky.social · 01/12/2025
Advance #Care Planning in #Dialysis Patients with a #Conversation #Game #VisualAbstract by Husam Alzayer www.kireports.org/article/S2468-024…
021
Reposted by Husam Alzayer
Nephrology Journal Club @nephjc.bsky.social · 18/11/2025
Tonite 11/18/25 on #Bluesky 9pm EST We are discussing ORIGIN3 and atacicept in IgAN. APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻) It's going to be Wicked good. 🧙‍♀️ #NephJC Summary by @notjustdialysis.bsky.social www.nephjc.com/news/atacicept-origin3-gtfb36
nephjc.com
Attacking the Origin of IgAN: ORIGIN3 and Atacicept — NephJC
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
0128
Reposted by Husam Alzayer
Nephrology Journal Club @nephjc.bsky.social · 18/11/2025
Check out the awesome visual abstract by @salinesolut.bsky.social Attacking the origins of IgAN with atacicept ⚔️ www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
nephjc.com
ORIGIN-3: The Visual Abstract — NephJC
Atacicept, BAFF/APRIL inhibition in IgAN
01212
Reposted by Husam Alzayer
ISNkidneycare @theisn.org · 07/11/2025
📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Impact of Donor and Recipient Diabetes on Posttransplant Outcomes: Gradually Seeing the Wood for the Trees www.kireports.org/ar... @husamjz.bsky.social
041
Husam Alzayer @husamjz.bsky.social · 31/10/2025
Glad to share our recent publication of diffuse cortical necrosis in native kidneys of a patient with #sickle_cell_trait. Although uncommon, patients with SCT can present with end-organ damage, and vigilance should be maintained when managing these patients. karger.com/cnd/article/...
karger.com
Diffuse Cortical Necrosis of Native Kidneys in Sickle Cell Trait: A Case Report
Abstract. Introduction: Sickle cell disorders are the most common hereditary hematological disorders; sickle cell trait (SCT) is largely benign with mild clinical manifestations, if any. Renal cortica...
010
Reposted by Husam Alzayer
kireports.bsky.social @kireports.bsky.social · 30/09/2025
🧵Tweetorial Alert 🧵 1/ Hey #NephSky! Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
153
Reposted by Husam Alzayer
Brian Rifkin @brianrifkin.bsky.social · 09/09/2025
Check out the latest @kireports.bsky.social community blog from @husamjz.bsky.social Anticoagulantion in ESRD patients with atrial fibrillation: www.kireportscommunity.org/post/bleeding-clotting-and-kidney-disease-in-atrial-fibrillation-can-factor-xi-inhibitors-change-the-g
kireportscommunity.org
Bleeding, Clotting, and Kidney Disease in Atrial Fibrillation: Can Factor XI Inhibitors Change the Game?
By. Husam Alzayer, MD, MSc, MRCPIReviewed by Sophia Ambruso, DOIntroduction Bleeding and thrombosis represent one of the many paradoxes faced by patients with kidney disease. As kidney function declin...
087
Reposted by Husam Alzayer
Nephrology Journal Club @nephjc.bsky.social · 25/06/2025
1/10 Last #NephJC we discussed the use of nudges 🫵 #TenPostNephJC In this study e-nudges (email) were sent to general practitioners (GPs) & patients to see if the uptake of goal-directed medical therapy (GDMT) in diabetic CKD could be increased. Read the article 👇 pubmed.ncbi.nlm.nih.gov/40481660/
165
Reposted by Husam Alzayer
Nephrology Journal Club @nephjc.bsky.social · 24/06/2025
👉We all need little nudges to do the right thing. Join us 6/24/25 at 9pm EST as we chat about E-Nudges to improve goal directed medical therapy (GDMT) in CKD. #NephJC #NephSky Blog by @nephroseeker.medsky.social @dramiliflores.bsky.social @husamjz.bsky.social www.nephjc.com/news/nudge-ckd
nephjc.com
Are E-Nudges Enough to Push Guideline-Based CKD Therapy? — NephJC
This week, we will discuss a registry trial: can a nationwide nudge fix a CKD treatment gap?
0108
Reposted by Husam Alzayer
kireports.bsky.social @kireports.bsky.social · 21/04/2025
Kidney Outcomes in Patients With Hereditary #Transthyretin #Amyloid Nephropathy Treated With Transthyretin #Stabilizers And Gene-Silencer Therapies #VisualAbstract by @Husamjz www.kireports.org/ar...
051
Reposted by Husam Alzayer
kireports.bsky.social @kireports.bsky.social · 04/04/2025
🔔Skeetorial Alert 🔔 1/ Hey #NephSky #MedSky! Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social
143
Reposted by Husam Alzayer
Nephrology Journal Club @nephjc.bsky.social · 24/03/2025
Happening this week! The @kdigo.org guidelines in #ADPKD #PKD on #NephJC www.nephjc.com/news/adpkd-k... Summary from @brianrifkin.bsky.social
nephjc.com
KDIGO 2025 ADPKD Guidelines Review — NephJC
This week, we will discuss the first iteration of KDIGO’s 2025 guidelines on ADPKD.  These guidelines are a result of a decade of global collaboration between physicians, researchers, advocates, ...
02411
Reposted by Husam Alzayer
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 15/03/2025
Ugh This is a nephrologist (And an NSMC internship grad) #NephSky #MedSky
24525
Reposted by Husam Alzayer
kireports.bsky.social @kireports.bsky.social · 12/03/2025
Interaction Between #APOL1 #Genetic Risk and Neighborhood Socioeconomic Status for #Kidney Outcomes in a United States Cohort #VisualAbstract by @husamjz.bsky.social www.kireports.org/ar...
022
Reposted by Husam Alzayer
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 06/03/2025
Announcing the #NephJC internship, @nephjc.bsky.social and @kireports.bsky.social joining forces www.nephjc.com/intern-app for details and to apply! #NephSky
nephjc.com
NephJC Editorial Internship — NephJC
04236
Reposted by Husam Alzayer
kireports.bsky.social @kireports.bsky.social · 14/02/2025
Systematic Review of the Effects of #Iron on #Cardiovascular, #Kidney and Safety Outcomes in Patients With Chronic Kidney Disease #CKD #VisualAbstract by @Husamjz www.kireports.org/ar... @bernardchan33 @brendonneuen
054
Reposted by Husam Alzayer
kireports.bsky.social @kireports.bsky.social · 08/01/2025
#Pharmacokinetics and #SideEffects of Δ9-tetrahydrocannabinol and #Cannabidiol in Patients with Different Stages of Chronic Kidney Disease #CKD #VisualAbstract by @Husamjz www.kireports.org/ar...
021
Reposted by Husam Alzayer
CORE IM @coreimpodcast.bsky.social · 27/11/2024
1/ 🚨 NEW #5Pearls: Peripheral Artery Disease (PAD) Let’s learn: 🚦When to suspect PAD 🚦PAD workup 🚦How to ⬆️ quality of life 🚦How to ⬇️ CV mortality 🚦Role of anti-thrombotics & anticoagulation 🚦Who needs revascularization 🖥️: t.co/dXfmA3Wx3c
t.co
https://www.coreimpodcast.com/2024/11/27/peripheral-arterial-disease-5-pearls-segment/
1164
Reposted by Husam Alzayer
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 10/11/2024
If you haven't already - please consider signing the ISN petition for the WHO to consider kidney health as a global priority We explain why with link to sign (takes 2 minutes - open to all) www.nephjc.com/news/isn-who...
nephjc.com
Making Kidney Health a Global Priority — NephJC
Let’s pus the WHO to make Kidney Health a global priority
12716